Table 5 General characteristics of the COVID-19 vaccinated group and the COVID-19 vaccine hesitant group
Characteristics | Vaccinated group (n = 132, 55.5%) | Vaccine hesitant group (n = 106, 44.5%) | p value |
|---|---|---|---|
Sex, male/female (%) | 95/37 (72/28) | 69/37 (65.1/34.9) | 0.255* |
Age group, n (%) | 0.164* | ||
< 43 years | 64 (48.5) | 61 (57.5) | |
≥ 44 years | 68 (51.5) | 45 (42.5) | |
Occupation, n (%) | 0.676† | ||
Employee | 69 (52.3) | 50 (47.2) | |
Independent | 35 (26.5) | 29 (27.4) | |
Unemployed/Retired | 28 (21.2) | 27 (25.5) | |
Income in US$ per month, n (%) | 0.229* | ||
≤$20 | 38 (28.8) | 34 (32.1) | |
$21–100 | 57 (43.2) | 50 (47.2) | |
$101–200 | 25 (18.9) | 10 (9.4) | |
≥$201 | 12 (9.1) | 12 (11.3) | |
Smoking habits, yes (%) | 47 (35.6) | 28 (26.4) | 0.129* |
Drinking habits, yes (%) | 5 (3.8) | 6 (5.7) | 0.546† |
Illicit drug use, yes (%) | 13 (9.8) | 5 (4.7) | 0.137* |
STDs history, yes (%) | 45 (34.1) | 30 (28.3) | 0.385* |
Time since HIV diagnosis, n (%) | 0.053* | ||
≤ 1 year | 25 (18.9) | 35 (33) | |
2–5 years | 23 (17.4) | 18 (17) | |
6–10 years | 20 (15.2) | 17 (16) | |
11–15 years | 23 (17.4) | 18 (17) | |
≥ 16 | 41 (31.1) | 18 (17) | |
Presence of at least one comorbidity, yes (%) | 53 (40.2) | 31 (29.9) | 0.167* |
AIDS-associated diseases history, yes (%) | 36 (27.3) | 41 (38.7) | 0.08* |
COVID-19 history, yes (%) | 24 (18.2) | 19 (17.9) | 0.992* |